Home

Stephen David Prior, Chief Strategy Officer: AN2 Therapeutics ANTX Sell · Filed 01/07

Trade details

Type
Insider sale
Amount
$3,604
Shares · price
3,604 sh · $1.00 a share
Held after
61,944 sh
Trade date
26/01/05
Filed
26/01/07
Days to filing
2 days

Sold 5.5% of holdings

Share of holding sold
5.5%

AN2 Therapeutics trades, last 26 weeks

What else happened in AN2 Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/06~02/04

Stephen David Prior's recent trades

  • Stephen David Prior

    SellAN2 Therapeutics

    $2,887

    Filed 01/07

  • Stephen David Prior

    SellAN2 Therapeutics

    $872

    Filed 25/11/06

  • Stephen David Prior

    SellAN2 Therapeutics

    $2,719

    Filed 25/01/07

Stephen David Prior, Chief Officer — sold $3,604 of AN2 Therapeutics ANTX · 5.5% of holdings | Whalegun